Class II molecules of the major histocompatibility complex (MHC) present processed foreign antigens to CD4+ T cells. Class II genes are highly polymorphic, and this polymorphism in class II loci is a feature unique to MHC that determines the efficiency that CD4+ T cells recognize a specific antigen (1) . The inheritance of MHC genes and their antigen expression may influence the susceptibility to autoimmune diseases. The best example is rheumatoid arthritis, where a conserved sequence of amino acids in the third hypervariable region of the DRA1 chain, called shared epitope (2) , has been found to be associated with both disease susceptibility and severity (3) . Hence, the HLA-DRB1*04 allelic group such as *0401, *0404, *0405, and *0408, which carried the shared epitope of amino acids at position 70Y74 of the DRA1 chain, were associated with rheumatoid arthritis, whereas other HLA-DRB1*04 alleles such as *0402 or *0403 that did not carry that sequence were not associated with the disease (2) . Polymorphic differences between DRA chains may influence the immune response and determine which particular peptides are bound by HLA-DR molecules. However, the exact role of Class II molecules in the pathogenesis of autoimmune disease remains unknown.
Autoimmunity seems to be associated with the pathogenesis of some inner ear diseases (4), including rapidly progressive bilateral sensorineural hearing loss (SNHL) or autoimmune inner ear disease (5), sudden SNHL (6), and Ménière's disease (MD) (7) . Early studies had determined an association between MD and the HLA Cw7 antigen in 41 British patients (8) , and with the allele HLA-DRB1*1602 in a Japanese population (9) , but these results were not consistent. Later studies have not confirmed these findings in Korean (10) or Spanish populations in MD (11) . These varying results can be explained because of the differences in ethnic background or the criteria to define MD. Because the criteria to define MD are clinical (SNHL, vertigo, tinnitus, and aural fullness), it is possible that different causes (genetic, epigenetic, environmental) can produce the clinical phenotype of MD. This makes the selection of individuals with MD a key point to identify an allele that may increase susceptibility.
Bilateral MD is an aggressive form of the disease affecting both ears that usually determines severe SNHL and chronic disequilibrium because of bilateral vestibular loss (12) . The endolymphatic hydrops starts affecting one ear, which results in the second ear getting affected between 2 and 12 years after (13) . Patients with bilateral involvement experience an increased disruption of daily life activities and respond poorly to therapy, resulting in a significant handicap (14) .
The aim of this study was to analyze the associations of HLA DRB1* and DQB1* alleles in patients with definite bilateral MD in two different ethnically defined populations.
MATERIALS AND METHODS

Patients
Eighty patients (38 men and 42 women) with definite bilateral MD according to the diagnostic scale for MD of the American Academy of OtolaryngologyYHead and Neck Surgery (AAO-HNS) were included in a prospective multicenter study between January 2004 and October 2006 (9) . Group 1 consisted of 37 patients from the area of Galicia (northwest of Spain), and Group 2 were 43 cases from the southeast (Almeria and Granada) and east (Valencia) areas of Spain. Five hospitals recruited patients for this study: Hospital Clinico Universitario from Santiago de Compostela and Hospital de Pontevedra for Group 1, and Hospital La Fe from Valencia, Hospital Virgen de las Nieves from Granada, and Hospital de Poniente from El Ejido, Almeria included the Mediterranean cases for Group 2. The subjects' informed consent was obtained to participate in the study according to the Declaration of Helsinki, and the local institutional committees approved the study.
A complete audiologic, vestibular, and functional evaluation was performed in all patients following the AAO-HNS guidelines to define stage, class, and functional status in each patient (15) . Individuals with criteria for unilateral MD or probable or possible bilateral MD according to the AAO-HNS guidelines were excluded from the study. Laboratory examinations included cytomegalovirus, Borrelia, and lues serologic tests to rule out endolymphatic hydrops secondary to these infections.
HLA Typing
Blood samples were obtained from each patient to type Class II genes. Typing was performed using low-and highresolution techniques previously described (16) . Briefly, DNA was obtained from whole peripheral blood by Qiagen protocol (Valencia, CA, USA), and HLA typing was performed for low resolution with sequence-specific oligonucleotide technique from Dynal (Oslo, Norway) using loci-specific primers.
High-resolution typing was performed by a sequence-based typing kit from Applied Biosystems, and sequences were analyzed by MathTools software in an ABI PRISM 377 DNA sequencer (Applied Biosystems, Foster City, CA, USA).
Statistical Analysis
The antigen and allele frequencies were calculated on each group, and they were compared with two ethnically matched control groups from the same regions. The strength of association between bilateral MD and DRB1 and DQB1 alleles was estimated using odds ratios (ORs) and 95% confidence intervals. Levels of significance were determined using contingency tables with Fisher's exact test. Probability values (p) were corrected by multiplying the p value by the number of alleles compared (n = 29 alleles for HLA-DRB1* gene).
RESULTS
The clinical features of both groups are shown in Table 1 . Patients had been suffering for an average of 12 years (median, 10 yr) in both groups, and the distribution of age and sex was similar in both. Hearing stage was referred to the best ear, and most patients were on Stages 3 and 4 (severe to profound hearing loss). Simultaneous bilateral SNHL was found in 4 of 37 subjects in the northwestern group and in 8 of 43 subjects in the southeast group, whereas delayed hearing loss was observed in the second ear in 33 of 37 and 35 of 43 subjects, respectively. Vertigo frequency in the last 6 months was low, as expected for a long time-course (910 yr) disease, and more than 45% of individuals did not refer spells of vertigo in the last 6 months. Impairment of daily activities was evaluated by the 
DISCUSSION
Our data indicate that there is a significant association between the allele HLA-DRB1*1101 and bilateral MD in a Mediterranean population from Spain. The allele DRB1*1101 was found in 19% of patients and 6% of controls in our study, suggesting that a significant number of patients with bilateral MD can have an immune basis. Unfortunately, this association was not found in the population from Galicia when they were compared with ethnically matched controls. HLA-DQB1 alleles in bilateral MD did not differ from controls in both populations. These varying results according to ethnic background suggest that MHC alleles may not be a significant factor associated with the pathogenesis of MD, but only a genetic marker in linkage disequilibrium, with one of the genes responsible for the disease.
Immunogenetic studies in patients with sensorineural hearing disorders have suggested a role for the MHCencoded genes in disease pathogenesis (17) . Allelic specificities of Class II genes have been found to be associated with progressive SNHL (18) and sudden SNHL (6) .
The cause of MD is likely to be multifactorial, genetic predisposition being one of the factors (19) . A pro51-toser mutation in the COCH gene, located in chromosome 14q12-q13, in one large Belgian and two small Dutch families with autosomal dominant nonsyndromic progressive SNHL associated with vestibular dysfunction (DFNA9) was related to familiar MD (20) . More than 25% of carriers of this mutation showed episodes of vertigo, tinnitus, aural fullness, and SNHL, consistent with the criteria for MD. However, later studies demonstrated that patients with sporadic MD do not carry mutations in the COCH gene (21, 22) .
The finding of elevated levels of circulating immune complexes in many patients with MD, especially in the active phase, has supported the hypothesis of autoimmunity in MD (23, 24) . Immunohistochemical studies have demonstrated deposits of C3 and C1q in the membranous labyrinth located at the basal membrane, subepithelial connective tissue, vestibular ganglion, and endolymphatic sac of patients with MD (25) . It seems that immune injury may be induced in the inner ear at sites where immune complexes are deposited in the vessels. Therefore, if deposits of immune complexes in the endolymphatic sac impair its resorptive function, this can result in endolymphatic hydrops.
Many studies have reported the high frequency of nonspecific autoantibodies in 50 to 70% patients in MD, the antinuclear antibodies found in 37.5% cases of bilateral MD (21, 26) being the most common. Moreover, different studies using Western blot immunoassay have found specific circulating autoantibodies in MD against a 68-kDa antigen from human inner ear tissue (27) and anti-HSP70 antibodies in 37% of patients with unilateral MD and in 59% of bilateral MD (28) . Recently, P0 antigen, a 30-kDa protein involved in myelin folding, was suggested as a diagnostic marker for bilateral MD because immunoglobulin G autoantibodies against the P0 antigen were found in 100% (10 of 10) patients with bilateral MD (29) .
Our study suggests that the inheritance of MHC Class II genes, particularly the HLA-DRB1* gene, may influence the susceptibility to develop bilateral MD. Although early studies identified an association between the HLA-Cw7 antigen and MD (8) , later series with a larger sample failed to demonstrate differences in phenotypic frequencies in Class I or II antigens (11) . The HLA-DRB1* gene is a highly polymorphic marker mainly due to diversification of the exon-2 sequences encoding the A-sheet. The allele HLA-DRB1* 1602 was found to be associated in 7.5% of Japanese in a sample of 20 individuals with MD (9), but association with this allele was not confirmed in bilateral MD in our Spanish population. In contrast, we found a significant association with DRB1*1101 in a population of bilateral disease from southeast Spain.
If allelic specificities of HLADRB1* gene increase susceptibility to bilateral MD, the immunologic alterations found in MD can define a subset of subjects with immunomediated inner ear disease with vestibular involvement that can potentially benefit from immunosuppressive therapy in MD.
CONCLUSION
The allele HLA-DRB1*1101 and the allelic group DRB1*11 may determine an increased susceptibility to develop bilateral MD in the southern European population.
